Teva is primed for a big bounce after years of underperformance, Barclays says
Teva to axe 14,000 jobs despite uproar in Israel | Financial Times
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel
In letter to Israeli PM, Teva CEO apologizes for drug-maker's sorry state | The Times of Israel
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals Overview | SignalHire Company Profile
Teva to be Sole Distributor of COVID-19 Vaccines in Israel | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Kislev 5781 – December 6, 2020 | JewishPress.com
Teva plans massive layoffs; Overland Park office's future unclear - Kansas City Business Journal